Allotment of 2,96,320 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022.
Extinguishment of 16,00,000 Equity Shares of Jagsonpal Pharmaceuticals Limited.
Please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
Submission of copy of Post Buy Back Public Advertisement related to Buy back of shares of Company.
Resignation of an Independent Director.
Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company
Submission of Letter of Offer for Buy- Back upto 16,00,000 Equity Shares at price of INR-250/- per share amounting to INR-40,00,00,000/-
Earning Call Transcript for meeting held on April 28, 2026
Newspaper Advertisement- Extract of Audited Financial Results for FY 26
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 60.15 | 57.83 | 47.23 | 43.49 | 61.44 | 74.69 | 74.03 | 58.56 | 75.61 | 74.47 | 72.95 | 64.20 |
| YOY Revenue Growth % | -0.73% | -4.46% | -21.46% | -21.58% | 2.14% | 29.16% | 56.72% | 34.66% | 23.07% | -0.3% | -1.46% | 9.64% |
| Other Income | 2.00 | 2.27 | 2.52 | 2.49 | 1.44 | 1.65 | 2.32 | 2.77 | 2.83 | 3.03 | 2.98 | 3.17 |
| Total Income | 62.15 | 60.10 | 49.76 | 45.97 | 62.88 | 76.35 | 76.35 | 61.33 | 78.44 | 77.49 | 75.92 | 67.37 |
| Total Expenses + | 52.06 | 50.14 | 44.48 | 41.44 | 52.49 | 60.98 | 60.86 | 52.41 | 64.01 | 60.68 | 59.32 | 55.62 |
| Cost of Materials Consumed | 7.53 | 4.91 | 5.88 | 3.79 | 4.39 | 5.20 | 5.27 | 3.49 | 5.33 | 3.84 | 3.95 | 2.99 |
| Employee Benefit Expense | 13.70 | 11.70 | 11.64 | 11.45 | 14.74 | 16.68 | 18.08 | 16.57 | 19.44 | 18.18 | 17.58 | 15.55 |
| Other Expenses | 15.53 | 16.85 | 12.46 | 11.71 | 14.16 | 15.37 | 13.59 | 11.56 | 15.03 | 12.63 | 12.65 | 13.73 |
| Operating Profit | 8.09 | 7.69 | 2.76 | 2.05 | 8.95 | 13.72 | 13.17 | 6.15 | 11.61 | 13.78 | 13.63 | 8.59 |
| OPM % | 13.5% | 13.3% | 5.8% | 4.7% | 14.6% | 18.4% | 17.8% | 10.5% | 15.3% | 18.5% | 18.7% | 13.4% |
| Profit Before Tax + | 10.09 | 9.96 | 5.28 | 4.54 | 7.11 | 15.37 | 38.67 | 8.71 | 14.43 | 16.81 | 14.52 | 11.76 |
| Tax Expense | 2.61 | 2.49 | 1.32 | 0.99 | 1.78 | 3.91 | 6.68 | 2.13 | 3.64 | 4.24 | 3.57 | 2.99 |
| Tax % | 25.9% | 25% | 24.9% | 21.8% | 25% | 25.4% | 17.3% | 24.4% | 25.2% | 25.2% | 24.6% | 25.5% |
| Profit After Tax | 7.48 | 7.47 | 3.96 | 3.55 | 5.33 | 11.46 | 31.99 | 6.58 | 10.80 | 12.57 | 10.95 | 8.76 |
| EPS (Basic) | 2.85 | 2.84 | 1.48 | 1.31 | 1.94 | 4.29 | 4.74 | 0.98 | 1.60 | 1.88 | 1.67 | 1.25 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 287.23 | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 | 158.57 |
| YOY Revenue Growth % | 6.89% | 28.76% | -11.83% | 4.7% | 20.3% | 18.53% | - |
| Other Income | 12.00 | 8.19 | 9.28 | 5.73 | 3.34 | 4.39 | 2.53 |
| Total Income | 299.22 | 276.91 | 217.98 | 242.45 | 229.43 | 192.34 | 161.09 |
| Total Expenses + | 239.62 | 226.73 | 188.11 | 204.18 | 202.11 | 170.47 | 130.63 |
| Cost of Materials Consumed | 16.11 | 18.34 | 22.10 | 31.21 | 40.42 | 38.63 | 36.78 |
| Employee Benefit Expense | 70.74 | 70.93 | 48.49 | 56.41 | 57.68 | 53.98 | 50.37 |
| Other Expenses | 54.04 | 50.27 | 57.17 | 53.04 | 46.84 | 34.11 | 43.47 |
| Operating Profit | 47.60 | 41.98 | 20.59 | 32.53 | 23.98 | 17.48 | 27.93 |
| OPM % | 16.6% | 15.6% | 9.9% | 13.7% | 10.6% | 9.3% | 17.6% |
| Profit Before Exceptional | 59.60 | 50.17 | 29.87 | 38.27 | 27.32 | 21.87 | 9.41 |
| Exceptional Items | -2.08 | 19.69 | 0.00 | -3.46 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 57.52 | 69.86 | 29.87 | 34.81 | 27.32 | 21.87 | 9.41 |
| Tax Expense | 14.44 | 14.50 | 7.41 | 8.09 | 7.73 | 4.81 | 1.54 |
| Tax % | 25.1% | 20.8% | 24.8% | 23.2% | 28.3% | 22% | 16.4% |
| Profit After Tax | 43.08 | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 | 7.87 |
| EPS (Basic) | 6.40 | 8.26 | 8.49 | 10.20 | 7.48 | 6.51 | 3.00 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Non-Current Assets + | 173.59 | 117.07 | 17.82 | 30.39 | 57.68 | 43.73 | 0.00 |
| Property, Plant & Equipment | 0.57 | 0.61 | 0.91 | 18.35 | 22.37 | 23.35 | 0.00 |
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 1.12 | 20.58 | 12.06 | 0.00 |
| Goodwill | 9.69 | 9.69 | 0.00 | 0.00 | 0.03 | 0.03 | 0.00 |
| Other Intangible Assets | 75.04 | 84.15 | 8.39 | 5.93 | 2.35 | 0.00 | 0.00 |
| Current Assets + | 143.09 | 161.19 | 199.25 | 164.56 | 110.78 | 120.48 | 0.00 |
| Inventories | 14.64 | 15.20 | 15.00 | 20.68 | 29.74 | 29.72 | 0.00 |
| Trade Receivables | 17.19 | 13.18 | 10.95 | 20.87 | 15.58 | 12.66 | 0.00 |
| Cash and Cash Equivalents | 10.04 | 11.22 | 12.76 | 11.05 | 26.03 | 58.94 | 0.00 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 22.14 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | |||||||
| Total Equity | 276.17 | 239.95 | 187.40 | 158.89 | 130.86 | 121.93 | 0.00 |
| Equity Share Capital | 13.39 | 13.28 | 13.22 | 13.10 | 13.10 | 13.10 | 0.00 |
| Other Equity | 262.78 | 226.67 | 174.18 | 145.79 | 117.76 | 108.83 | 0.00 |
| Non-Current Liabilities | 12.21 | 12.41 | 10.55 | 8.48 | 3.44 | 1.88 | 0.00 |
| Current Liabilities | 28.30 | 25.90 | 19.13 | 27.57 | 34.16 | 40.40 | 0.00 |
| Total Liabilities | 40.51 | 38.31 | 29.68 | 36.06 | 37.60 | 42.27 | 0.00 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 46.81 | 55.30 | 35.17 | 40.15 | 5.60 | 28.22 | 0.00 |
| Cash from Investing Activities | -35.65 | -45.15 | -24.55 | -51.62 | -26.21 | -2.26 | 0.00 |
| Cash from Financing Activities | -12.15 | -11.70 | -8.91 | 0.00 | -12.30 | -6.83 | 0.00 |
| Net Increase/Decrease in Cash | -0.99 | -1.55 | 1.71 | -11.47 | -32.91 | 19.13 | 0.00 |